MAPT and Alzheimer disease: Several neuroimaging techniques have been developed for AD diagnosis, including structural MRI (sMRI), functional MRI (fMRI), [18F] fluorodeoxyglucose PET (FDG-PET), Aβ-PET, and tau-PET.